[1] Article Title: Epidemiological study of congenital myasthenic syndromes based on national electronic health database of Turkiye
	•	Line(s): 1
	•	Section: Title Page
	•	Quote(s): Epidemiological study of congenital myasthenic syndromes based on national electronic health database of Turkiye

⸻

[2] Publication Year: 2025
	•	Line(s): 82
	•	Section: Turkish Abstract Footer
	•	Quote(s): (NCI-2025-4-1)

⸻

[3] Region: Europe
	•	Line(s): 1–5
	•	Section: Title Page (Affiliations)
	•	Quote(s): Turkiye (Turkey is located in both Europe and Asia; however, in epidemiological contexts, it is typically grouped under Europe.)

⸻

[4] Country: Turkiye
	•	Line(s): 1, 5
	•	Section: Title Page
	•	Quote(s): Republic of Turkiye Ministry of Health, Ankara, Turkiye

⸻

[5] Coverage Area: National
	•	Line(s): 6, 21
	•	Section: Abstract
	•	Quote(s): national electronic health registry, first comprehensive nationwide epidemiological analysis

⸻

[6] Study Design: Retrospective national cohort study
	•	Line(s): 10
	•	Section: Abstract (Methods)
	•	Quote(s): The study was a retrospective national cohort study

⸻

[7] Study Population: Patients with CMS identified via ICD-10 code G70.2
	•	Line(s): 10
	•	Section: Abstract (Methods)
	•	Quote(s): patients with at least three G70.2 ICD-10 code entries

⸻

[8] Population Characteristics: NR
	•	Line(s): 12–14
	•	Section: Abstract (Results)
	•	Quote(s):
The mean age at diagnosis was 20.59±21.65 years (median: 12.00, min-max: 0-86).
females comprising 48.8% of the cohort.
58.6% were diagnosed before the age of 18, and 12.3% before the age of one.

⸻

[9] Data Source Type: National electronic health registry
	•	Line(s): 6
	•	Section: Abstract (Objective)
	•	Quote(s): utilizing data from the national electronic health registry

⸻

[10] Data Source Details: Patients identified by ≥3 entries of ICD-10 code G70.2 in national database
	•	Line(s): 10
	•	Section: Abstract (Methods)
	•	Quote(s): patients with at least three G70.2 ICD-10 code entries between 1 January 2015 and 22 May 2024

⸻

[11] Study Timeline Type: Retrospective
	•	Line(s): 10
	•	Section: Abstract (Methods)
	•	Quote(s): The study was a retrospective national cohort study

⸻

[12] Number of Sites: NR
	•	Line(s): NR
	•	Section: NR
	•	Quote(s): NR

⸻

[13] Study Start Year: 1 January 2015
	•	Line(s): 10
	•	Section: Abstract (Methods)
	•	Quote(s): between 1 January 2015 and 22 May 2024

⸻

[14] Study End Year: 22 May 2024
	•	Line(s): 10
	•	Section: Abstract (Methods)
	•	Quote(s): between 1 January 2015 and 22 May 2024

⸻

[15] Main Ethnicity: NR
	•	Line(s): NR
	•	Section: NR
	•	Quote(s): NR

⸻

[16] Ethnicity Details: NR
	•	Line(s): NR
	•	Section: NR
	•	Quote(s): NR

⸻

[17] Disease Studied: Congenital Myasthenic Syndromes (CMS)
	•	Line(s): 3
	•	Section: Abstract (Objective)
	•	Quote(s): Congenital myasthenic syndromes (CMS) represent a group of genetically heterogenous disorders

⸻

[18] Diagnosis Method: Clinical diagnosis based on ICD-10 coding
	•	Line(s): 10
	•	Section: Abstract (Methods)
	•	Quote(s): patients with at least three G70.2 ICD-10 code entries

⸻

[19] Diagnosis Criteria Details: At least three ICD-10 G70.2 entries in national database
	•	Line(s): 10
	•	Section: Abstract (Methods)
	•	Quote(s): patients with at least three G70.2 ICD-10 code entries

⸻

[20] Disease Phase: NR
	•	Line(s): NR
	•	Section: NR
	•	Quote(s): NR

⸻

[21] Cohort Age Group: Mixed
	•	Line(s): 13
	•	Section: Abstract (Results)
	•	Quote(s): 58.6% were diagnosed before the age of 18

⸻

[22] Female % in Cohort: 48.8%
	•	Line(s): 12
	•	Section: Abstract (Results)
	•	Quote(s): females comprising 48.8% of the cohort

⸻

[23] Consanguinity: NR
	•	Line(s): NR
	•	Section: NR
	•	Quote(s): NR